Advertisement
UK markets close in 1 hour 22 minutes
  • FTSE 100

    8,382.18
    +28.13 (+0.34%)
     
  • FTSE 250

    20,544.32
    +52.33 (+0.26%)
     
  • AIM

    782.76
    +2.93 (+0.38%)
     
  • GBP/EUR

    1.1608
    -0.0015 (-0.13%)
     
  • GBP/USD

    1.2502
    +0.0005 (+0.04%)
     
  • Bitcoin GBP

    49,017.38
    -849.41 (-1.70%)
     
  • CMC Crypto 200

    1,318.81
    +18.72 (+1.44%)
     
  • S&P 500

    5,193.35
    +5.68 (+0.11%)
     
  • DOW

    39,158.06
    +101.67 (+0.26%)
     
  • CRUDE OIL

    79.43
    +0.44 (+0.56%)
     
  • GOLD FUTURES

    2,329.70
    +7.40 (+0.32%)
     
  • NIKKEI 225

    38,073.98
    -128.39 (-0.34%)
     
  • HANG SENG

    18,537.81
    +223.95 (+1.22%)
     
  • DAX

    18,665.43
    +167.05 (+0.90%)
     
  • CAC 40

    8,173.85
    +42.44 (+0.52%)
     

Better Buy: Ocugen or Novavax?

Better Buy: Ocugen or Novavax?

There may be a second wave of COVID-19 vaccines coming. With the hopes of widespread approval of each company's SARS-CoV-2 vaccine, Novavax (NASDAQ: NVAX) is already up nearly 90% year to date while Ocugen (NASDAQ: OCGN) is up over 300% in the same time frame. Patrick Bafuma: To begin, let's take a look at Novavax.